No access

Article

Published Online: April 1951

THERAPEUTIC RESULTS AND CLINICAL MANIFESTATIONS FOLLOWING THE USE OF TETRAETHYLTHIURAM DISULFIDE (ANTABUSE)

GEORGE P. CHILD, WALTER OSINSKI, ROBERT E. BENNETT, and EUGENE DAVIDOFFAuthors Info & Affiliations

Publication: American Journal of Psychiatry

Volume 107, Number 10

https://doi.org/10.1176/ajp.107.10.774

Get Access

Abstract

The observations made during the treatment of 120 chronic alcoholics with Antabuse are reported. Certain animal experiments are also described.

1. In large doses Antabuse is toxic to animals. Death by respiratory arrest is preceded by an ascending paralysis. The Antabuse in these large doses produces liver, spleen, kidney, and C.N.S. damage.

2. In human subjects, large doses produce gastro-intestinal and nervous symptoms. In therapeutic amounts there are no apparent effects on liver, kidney, blood, heart, or brain. Patients should not be given Antabuse until at least 4 days have elapsed since their last alcoholic debauch.

3. In rats a moderate dose of Antabuse markedly increases the toxicity of ethyl alcohol.

4. In patients on Antabuse therapy a definite pattern of reaction may be seen after a test dose of alcohol. This syndrome, subjectively and objectively, is much like that observed after the ingestion of a large quantity of alcohol at one time. Cardiovascular collapse may result. Supportive therapy and intravenous ascorbic acid may abort the syndrome. There is an increased blood acetaldehyde during the reaction.

5. The selection of patients for therapy must be on an individual basis. The patient must be willing to take the drug. He should have no organic disease that might endanger his life if he should imbibe a small amount of alcohol.

6. A test dose of alcohol is given each patient to determine the effectiveness of the Antabuse, and to give him the startling experience of becoming violently intoxicated on a very small amount of alcohol.

7. Intensive psychotherapy must be employed in the management of the alcoholic on Antabuse. The patient's family and friends and the A. A., social agencies, and others should be called upon for the rehabilitation of the patient.

8. Each Antabuse patient should carry a clinic card indicating that he is on Antabuse therapy, SO that if he should drink and have a reaction, emergency therapy may be started if required. Some experiences with such "slips" are described.

9. Of the 120 patients reported in this paper, 74 are improved. The initial "cure" rate was much higher. Most slips occurred at 3 months. The question is raised whether a test dose should be given every 3 months.

10. It is most important that the drug be administered under careful medical psychiatric supervision. Indiscriminate use of Antabuse by the private practitioner without the aid of a therapeutic regime, hospital or clinic, and without psychiatric consultation is to be condemned.

Get full access to this article

View all available purchase options and get full access to this article.

Get Access

Information & Authors

Information

Published In

American Journal of Psychiatry

Volume 107 • Number 10 • April 1951

Pages: 774 - 780

PubMed: 14819374

History

Published in print: April 1951

Published online: 1 April 2006

Authors

Details

GEORGE P. CHILD

View all articles by this author

WALTER OSINSKI

View all articles by this author

ROBERT E. BENNETT

View all articles by this author

EUGENE DAVIDOFF

View all articles by this author

Department of Physiology and Pharmacology, Albany Medical College.

Department of Psychiatry, Albany Medical College.

Trenton State Hospital.

Ellis Hospital.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format	RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks
Direct importt
Citation style
Style

Copy to clipboard
Tips for downloading citations

View Options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR^® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

THERAPEUTIC RESULTS AND CLINICAL MANIFESTATIONS FOLLOWING THE USE OF TETRAETHYLTHIURAM DISULFIDE (ANTABUSE)

Abstract

Get full access to this article